WO2021007626A1 - Oral medication for treating lipoedema - Google Patents

Oral medication for treating lipoedema Download PDF

Info

Publication number
WO2021007626A1
WO2021007626A1 PCT/BR2019/000026 BR2019000026W WO2021007626A1 WO 2021007626 A1 WO2021007626 A1 WO 2021007626A1 BR 2019000026 W BR2019000026 W BR 2019000026W WO 2021007626 A1 WO2021007626 A1 WO 2021007626A1
Authority
WO
WIPO (PCT)
Prior art keywords
lipedema
disease
treating
treatment
oral medication
Prior art date
Application number
PCT/BR2019/000026
Other languages
French (fr)
Portuguese (pt)
Inventor
Daniel Augusto BENITTI
Alexandre CAMPOS MORAES AMATO
Original Assignee
Benitti Daniel Augusto
Campos Moraes Amato Alexandre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benitti Daniel Augusto, Campos Moraes Amato Alexandre filed Critical Benitti Daniel Augusto
Publication of WO2021007626A1 publication Critical patent/WO2021007626A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Definitions

  • the present invention refers to a new and unprecedented drug for the treatment of “Lipedema”, which is a chronic hereditary dysfunction of fat distribution characterized by an increase in subcutaneous adipose tissue (lipohypertrophy), through a formulation that has been shown to be efficient in the treatment of the disease, using several components: Citrus sinensis, Curcumin, Piperina, among others.
  • the present invention aims to offer an appropriate treatment to people who develop Lipedema, through a remedy and a treatment that also consists of a creamy formulation, to be treated more specifically in another application for an invention patent, making unprecedented treatment in the world. Although it is a common disease that affects 11% of women, it is rarely diagnosed and, when diagnosed, there is no treatment available on the market.
  • the medicine is composed of: dry extract of cataloupe melon; Pyrroloquinoline Quinona; Citrus sinensis; Curcumin; Piperine; Lutein, Astaxanthin; Selenium chelate; Vitamin C; Quercetin and Bromelain.
  • Cantaloupe melon (Cucumis melo L.) is a bioavailable form of superoxide dismutase (SOD). SOD reduces oxidative stress by catalyzing the dismutation of superoxide into oxygen and hydrogen peroxide.
  • SOD causes the protection of cognitive function against stress, prevents diseases related to the metabolic syndrome, acts in the prevention of the preclinical stage of atherosclerosis by inhibiting vascular inflammation, decreasing the risk of cardiovascular diseases, decreasing the accumulation of lactic acid during exercise and promotes immune modulation. In the skin, it reduces the signs of aging, helping to maintain the structural integrity of the skin and collagen, in preventing allergies, in preparing the skin for sun exposure, in addition to reducing changes in post-inflammatory and solar hyperpigmentation. (References: Stejnborn, AS; Cloarec, M; Nakajima, S).
  • Metoxantin Pyrroloquinoline quinone is a tricyclic quinone that functions as a coenzyme in various bacterial oxide reductase reactions. Also known as methoxyantin, it is considered 100 times more potent than vitamin C, found naturally in foods such as: fermented soybeans, kiwi, parsley, green peppers, spinach, green tea, among others (RUCKER, 2001; TSUGE, 2005) - it is a essential nutrient that the organism cannot synthesize, being a cofactor of oxide-reduction reactions, acting as a powerful antioxidant, with the ability to neutralize free radicals, superoxides and hydroxides, resulting in the reduction of early cell aging, with the consequence of promoting healthy aging.
  • Citrus sinensis is an extract obtained from Moro Vermelha Vermelha, also known as false blood.
  • Moro red orange (Citrus sinensis L.) contains a variety of phytochemical components that contribute to the flavor and properties of the fruit. These substances include sugars like sucrose, fructose and glucose; organic acids (mainly citric, malic and isocitric acid); carotenoids, such as xanthophylls and carotenes; vitamins such as vitamin C, A, B1, B6 and B3; aromatic compounds, including various esters, alcohols, ketones, lactones and volatile hydrocarbons, in addition to polyphenols such as 8-hydroxycinnamic acid and bioflavonoids.
  • Bioflavonoids are composed of several phytochemicals, among which anthocyanins and flavanones stand out, which are present in the species extract in at least 90%. Studies indicate that these assets are responsible for limiting body weight gain, improving insulin sensitivity and decreasing serum triglyceride and total cholesterol levels.
  • Citrus sinensis also has anti-inflammatory, antioxidant and cardioprotective activities.
  • Citrus Sinensis can be beneficial for cholesterol control as well as weight reduction.
  • Curcuma longa is traditionally used for multiple 5
  • the rhizomes being the main part of the plant used in the preparations.
  • Rhizomes are mainly used to treat: skin wounds (327-332), flatulence (330, 333, 334), dyspepsia (330, 335, 336), arthritis (327, 337), gastritis (334, 335) , liver disorders (332, 338), jaundice (330, 332), cough (327, 339) and skin diseases (337), such as dermatitis (334, 340), dermatomycosis (341), scabies (330, 342), skin infections (343) and skin parasites (344).
  • rhizomes are also popularly reported in cases of: diabetes (327), leprosy (344), hirsutism (344), ulcers caused by HPV (344), itchy skin rashes (345), smallpox (328) , chickenpox (328), malaria (346), postpartum bleeding (347), muscle injury (348), asthma (330), worms (342), tonic, revitalizer, stimulant (332, 336), fever, diarrhea, expectorant and anti-inflammatory (334).
  • Piperine (4) is composed of a group 1, 3-benzodioxola (subunit A), next to a chain of pentadiene acid (subunit B) and the fragment piperidine (subunit C).
  • Piperic acid the acyl portion of the piperine molecule (subunits A and B)
  • Lutein is a type of carotenoid and, like all others, is not produced by the human body. It has important functions: it is a natural filter of blue light, which protects the eyes and skin from damage arising in daily life due to exposure to daylight and artificial lighting. environments. It is also a relevant antioxidant that provides protection against oxidative damage from “free radicals” produced by ultraviolet light, cigarette smoke and pollution.
  • the best natural sources of lutein are green and leafy vegetables, such as kale, spinach, chicory, celery and lettuce, green vegetables, orange-red tubers, fresh herbs and egg yolk.
  • Astaxanthin a carotenoid belonging to the xanthophyll class, has aroused great interest due to its antioxidant capacity and possible role in reducing the risk of some diseases. Astaxanthin can be found naturally in microalgae such as Haematococcus pluvialis and in the yeast Phaffia rhodozyma as it has also been considered the main carotenoid in salmon and crustaceans. Shrimp processing residues, usually discarded, are also an important source of astaxanthin.
  • the antioxidant activity of astaxanthin has demonstrated an important function in the modulation of biological functions related to lipid peroxidation, having beneficial effects in chronic diseases such as cardiovascular diseases, macular degeneration and cancer. Research has shown satisfactory effects of astaxanthin obtained from natural sources as well as that obtained synthetically, however studies in humans are limited to the use of natural sources.
  • organic minerals are minerals linked to an amino acid and have a greater capacity to be absorbed by the body. They can be of three types: 1. Mineral Amino Acid Chelate: when a mineral molecule is linked to a specific amino acid. It is easily assimilated by the body. 2. Mineral Complex Amino Acid: (specific and nonspecific) when a mineral molecule is linked to a complex amino acid. It is less absorbed than the previous one. 3. Mineral Proteinate: when a mineral molecule is linked to a polypeptide complex. It is the least absorbed of the three types: The difference between the three types is in the molecular weight, the constant stability of bonds and the amino acids used.
  • Chelated minerals have the advantage of being better bioavailable (up to 90% absorption, against 10 to 20% of inorganic minerals), without interfering with the absorption of other nutrients, without having side effects, or causing doppig.
  • medical prescription must be taken into account. If the request is only the pure mineral, which we call elementary content, the factor must be applied. If the prescription is chelated, no. To be sure at the time of prescription, the ideal is to evaluate by the prescribed dosage, so we know if the elementary is prescribed or not.
  • Selenium offers protection against several cancers and, in fact, against a wide spectrum of diseases such as: chronic diseases, such as arterosclerosis (coronary artery disease, cerebrovascular disease and peripheral vascular disease), cancer, degenerative joint disease (arthritis), cirrhosis and chronic obstructive pulmonary disease (emphysema).
  • chronic diseases such as arterosclerosis (coronary artery disease, cerebrovascular disease and peripheral vascular disease)
  • cancer degenerative joint disease (arthritis), cirrhosis and chronic obstructive pulmonary disease (emphysema).
  • Quercetin is an antioxidant flavonoid, which is present in food in the form of natural glycosides and can be found in vegetables, fruits and juices.
  • flavonoids especially Quercetin, have been studied in recent decades, highlighting the antioxidant, anticarcinogenic potential and their protective effects on the renal, cardiovascular and hepatic systems. It is also a powerful antioxidant and free anti-radicals, reducing the risk of death from coronary heart disease and decreasing the incidence of myocardial infarction.
  • Bromelain is a digestive enzyme of plant origin - Ananas comosus with anti-inflammatory action. In addition to its anti-inflammatory action, its efficiency in inhibiting the development of cancer cells has been studied. Recommendation for use Low Dosages: 50 to 100 mg / day, Larger Dosages: 500 mg / day Used in inflammatory processes of traumatic origin, infectious, vascular and rheumatic surgery. Properties Digestive enzyme, it has an anti-inflammatory action produced by the fibrinolytic and anti-fibriniquinic action of bromelains. Indications Used in inflammatory processes of traumatic origin, infectious surgery, vascular and rheumatic. Bromelain can also be used as an aid in digestion and for the treatment of high-grade burns.
  • Vitamin C ascorbic acid
  • the nutrient also has a strong antioxidant action, fighting free radicals.
  • Vitamin C increases the production of white blood cells, cells that are part of the immune system and that have the function of fighting microorganisms and foreign structures in the body.
  • the nutrient also increases the levels of antibodies in the body. Thus, the nutrient helps to strengthen the immune system, making our body less susceptible to disease.
  • Vitamin C prevents skin aging as it is essential for the natural production of collagen by the body.
  • Collagen is a protein that provides support and firmness to the skin.
  • vitamin C has an antioxidant action, that is, it neutralizes free radicals, protecting the skin against collagen degradation.
  • Vitamin C increases the bioavailability of non-heme iron, that of plant origin, in the body.
  • Vitamin C contributes to prevent vision problems due to aging. This is because the nutrient is one of the factors for the prevention of macula degeneration, part of the retina responsible for the perception of details. Other nutrients that prevent the problem are beta-carotene, vitamin E, zinc and copper.
  • Lipedema is a dysfunction of fat distribution, affecting almost exclusively women, whose tissues are structured differently from men.
  • the predisposition for lipedema is likely to be genetic.
  • the cause of this chronic disease is usually hormonal changes in the body, which happen during puberty, pregnancy or menopause. If the condition already exists, the symptoms are likely to worsen at these times in life.
  • Lipedema is characterized by an increase in subcutaneous adipose tissue (lipohypertrophy), swelling in the second half of the day and pain in the legs.
  • the fat cells of the lipedema have a different constitution, e.g. the fat reserve in the belly.
  • Lipedema is not a fat reserve due to excessive weight, but rather a pathological change in adipose tissue. However, excessive weight and weight fluctuations have a negative effect on lipedema.
  • lipedema is symmetrical: it causes changes in the "spine" type and deformations of the legs. Hips, thighs and legs are typically bulky.
  • Fig. 1 It shows an illustrative view of legs with lipedema swelling in early to more advanced stages; 41. Fig. 2 - It shows an illustrative view of the arm with swelling of the lipedema;
  • Fig. 3 - Shows an illustrative view of the thighs with swelling of the lipedema
  • Fig. 4 - It presents a view of the biosynthetic proposal scheme for the formation of piperine
  • Fig. 5 - Displays a view of the chemical component curcumin scheme.
  • the “ORAL MEDICATION TO TREAT LIPEDEMA is characterized by being a drug formulation for oral use for the treatment of lipedema (1) in humans (H) containing: dry melon extract cataloupe equivalent to 480UI super oxide dismutase (2), pyrroloquinoline quinone 5 mg (3), citrus sinensis 400 mg (4), curcumin 100 mg (5), piperine 2 mg (6), lutein 5 mg (7), astaxanthin 1 mg (8), selenium chelate 100 mcg (9), vitamin C 100 mg (10), quercetin 300mg (11) and bromelain 180mg (12).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

This is a product for use in the pharmaceutical sector. The present invention relates to a new and novel medication for treating lipoedema, which is a chronic hereditary fat distribution disorder characterized by an increase in subcutaneous adipose tissue (lipohypertrophy), by means of a formulation that has been shown to be effective in treating the disease, using various components: Citrus sinensis, Curcumin and Piperine, inter alia.

Description

“MEDICAMENTO ORAL PARA TRATAR LIPEDEMA” “ORAL MEDICATION TO TREAT LIPEDEMA”
1. Refere-se o presente invento a um novo e inédito medicamento para o tratamento do “Lipedema”, que é uma disfunção hereditária crónica da distribuição de gordura caracterizando-se por um aumento do tecido adiposo subcutâneo (lipo-hipertrofia), através de uma formulação que tem se mostrado eficiente no tratamento da doença, utilizando vários componentes: Citrus sinensis, Curcumina, Piperina, dentre outros. 1. The present invention refers to a new and unprecedented drug for the treatment of “Lipedema”, which is a chronic hereditary dysfunction of fat distribution characterized by an increase in subcutaneous adipose tissue (lipohypertrophy), through a formulation that has been shown to be efficient in the treatment of the disease, using several components: Citrus sinensis, Curcumin, Piperina, among others.
2. Destina-se o presente invento em oferecer um tratamento adequado às pessoas que desenvolvem o Lipedema, através de um rémedio e um tratamento que também é composto por uma formulação cremosa, a ser tratada mais especificamente em outro pedido de patente de invenção, tornando-se um tratamento inédito no mundo. Embora seja uma doença comum que acomete 11 % das mulheres, raramente é diagnosticada e, quando diagnosticada, não há tratamento disponível no mercado. 2. The present invention aims to offer an appropriate treatment to people who develop Lipedema, through a remedy and a treatment that also consists of a creamy formulation, to be treated more specifically in another application for an invention patent, making unprecedented treatment in the world. Although it is a common disease that affects 11% of women, it is rarely diagnosed and, when diagnosed, there is no treatment available on the market.
3. É uma medicação oral que associada a uma medicação tópica alivia os sintomas da doença e auxilia no emagrecimento evitando uma cirurgia e complicações psicológicas da evolução do quadro da paciente. Não existe tratamento medicamentoso para a doença. Apenas cirúrgico. Portanto, abre uma possibilidade de tratamento para uma população grande que sofre com os sintomas graves e perda de qualidade de vida. Fizemos um levantamento científico e na literatura a única opção de tratamento efetiva para a doença é cirúrgica com melhora de tratamento dos sintomas em 58% após 6 (seis) meses (Rapprich et al) e em nossa experiência cientificamente mensurada em projeto piloto tivemos melhora de 34,7% no sintomas com apenas 1 mês de tratamento. 4. O medicamento é composto de: extrato seco de melão cataloupe; Pirroloquinolina Quinona; Citrus sinensis; Curcumina; Piperina; Luteína, Astaxantina; Selenio quelato; Vitamina C; Quercetina e Bromelina. 3. It is an oral medication that associated with a topical medication relieves the symptoms of the disease and helps with weight loss avoiding surgery and psychological complications of the patient's evolution. There is no drug treatment for the disease. Surgical only. Therefore, it opens a possibility of treatment for a large population that suffers from severe symptoms and loss of quality of life. We carried out a scientific survey and in the literature the only effective treatment option for the disease is surgical with improvement in the treatment of symptoms in 58% after 6 (six) months (Rapprich et al) and in our scientifically measured experience in a pilot project, we have 34.7% in symptoms with only 1 month of treatment. 4. The medicine is composed of: dry extract of cataloupe melon; Pyrroloquinoline Quinona; Citrus sinensis; Curcumin; Piperine; Lutein, Astaxanthin; Selenium chelate; Vitamin C; Quercetin and Bromelain.
5. O melão de cantaloupe (Cucumis melo L.) é uma forma biodisponível de superóxido dismutase (SOD). A SOD reduz o estresse oxidativo ao catalisar a dismutação do superóxido em oxigénio e peróxido de hidrogénio. 5. Cantaloupe melon (Cucumis melo L.) is a bioavailable form of superoxide dismutase (SOD). SOD reduces oxidative stress by catalyzing the dismutation of superoxide into oxygen and hydrogen peroxide.
6. A SOD ocasiona a proteção da função cognitiva contra o estresse, previne doenças relacionadas à síndrome metabólica, atua na prevenção do estágio pré-clínico da aterosclerose ao inibir a inflamação vascular diminuindo o risco de doenças cardiovasculares, diminui o acúmulo de ácido lático durante o exercício e promove a modulação imunológica. Na pele, reduz os sinais de envelhecimento, auxiliando na manutenção da integridade estrutural da pele e do colágeno, na prevenção de alergias, na preparação da pele a exposição solar, além de reduzir as alterações de hiperpigmentação pós-inflamatória e solar. (Referencias: Stejnborn, AS; Cloarec, M ; Nakajima, S). 6. SOD causes the protection of cognitive function against stress, prevents diseases related to the metabolic syndrome, acts in the prevention of the preclinical stage of atherosclerosis by inhibiting vascular inflammation, decreasing the risk of cardiovascular diseases, decreasing the accumulation of lactic acid during exercise and promotes immune modulation. In the skin, it reduces the signs of aging, helping to maintain the structural integrity of the skin and collagen, in preventing allergies, in preparing the skin for sun exposure, in addition to reducing changes in post-inflammatory and solar hyperpigmentation. (References: Stejnborn, AS; Cloarec, M; Nakajima, S).
7. A Pirroloquinolina Quinona/ Proteção neurológica e mitocondrial Prevenção do envelhecimento precoce. 7. Pyrroloquinoline Quinone / Neurological and mitochondrial protection Prevention of premature aging.
8. Nome científico: Metoxantin A Pirroloquinolina quinona (PQQ) é uma quinona triclíclica que funciona como uma coenzima em várias reações óxidos redutase bacterianas. Também conhecida como metoxantin é considerada 100 vezes mais potente que a vitamina C, encontrada naturalmente em alimentos como: soja fermentada, kiwi, salsa, pimentão verde, espinafre, chá verde, entre outras (RUCKER, 2001 ; TSUGE, 2005) - é um nutriente essencial que o organismo não pode sintetizar, sendo um cofator de reações de óxi-redução, atuando como um potente antioxidante, com capacidade de neutralizar os radicais livres superóxidos e hidróxidos, resultando na redução do envelhecimento celular precoce, tendo como consequência a promoção do envelhecimento saudável. Melhora as funções cognitivas, promove a proteção mitocondrial, possui propriedades antioxidantes, protege o sistema imunológico e neurológico. Além disso, estudos mostram que o PQQ aumenta fatores de crescimento e contribui para a biogênese mitocondrial (OHWADA, 2008; YAMAGUCHI, 1993). Estudos mostram que PQQ pode melhorar a função cognitiva, qualidade do sono, alívio da fadiga mental e humor positivo (NAKANO, 2012). Outros estudos mostram que PQQ tem influência positiva sobre as funções cerebrais, melhorando a memória e atenção em idosos saudáveis (NAKANO, 2009). Por retardar o processo de envelhecimento, sugere-se que o PQQ pode prevenir cabelos brancos - este processo está intimamente ligado à degradação e ao desaparecimento progressivo de mitocôndrias e o excesso de radicais livres no bulbo capilar; aumenta os níveis de energia indispensáveis às células. 8. Scientific name: Metoxantin Pyrroloquinoline quinone (PQQ) is a tricyclic quinone that functions as a coenzyme in various bacterial oxide reductase reactions. Also known as methoxyantin, it is considered 100 times more potent than vitamin C, found naturally in foods such as: fermented soybeans, kiwi, parsley, green peppers, spinach, green tea, among others (RUCKER, 2001; TSUGE, 2005) - it is a essential nutrient that the organism cannot synthesize, being a cofactor of oxide-reduction reactions, acting as a powerful antioxidant, with the ability to neutralize free radicals, superoxides and hydroxides, resulting in the reduction of early cell aging, with the consequence of promoting healthy aging. It improves cognitive functions, promotes mitochondrial protection, has antioxidant properties, protects the immune and neurological systems. In addition, studies show that PQQ increases growth factors and contributes to mitochondrial biogenesis (OHWADA, 2008; YAMAGUCHI, 1993). Studies show that PQQ can improve cognitive function, quality of sleep, relief from mental fatigue and positive mood (NAKANO, 2012). Other studies show that PQQ has a positive influence on brain functions, improving memory and attention in healthy elderly people (NAKANO, 2009). By delaying the aging process, it is suggested that PQQ can prevent gray hair - this process is closely linked to the degradation and progressive disappearance of mitochondria and the excess of free radicals in the hair bulb; increases the energy levels indispensable to cells.
9. Propriedades · Antioxidante · Melhora a função cognitiva. · Neuroproteção · Booster mitocondrial · Aumenta a energia · Melhora o sistema imunológico · Auxilia no envelhecimento saudável · Ação cardioprotetora Comprovação de eficácia. 9. Properties · Antioxidant · Improves cognitive function. · Neuroprotection · Mitochondrial booster · Increases energy · Improves the immune system · Helps with healthy aging · Cardioprotective action Proving effectiveness.
10. Citrus sinensis é um extrato obtido da Laranja Vermelha Moro, também conhecida como falsa sanguínea. A laranja vermelha Moro (Citrus sinensis L.) contém uma variedade de componentes fitoquímicos que contribuem para o sabor e as propriedades do fruto. Estas substâncias incluem açúcares como sacarose, frutose e glucose; ácidos orgânicos (principalmente ácido cítrico, málico e isocítrico); carotenóides, como xantofilas e carotenos; vitaminas tais como a vitamina C, A, B1 , B6 e B3; compostos aromáticos, incluindo vários ésteres, álcoois, cetonas, lactonas e hidrocarbonetos voláteis, além de polifenóis como o ácido 8- hidroxicinâmico e os bioflavonóides. Os bioflavonóides são compostos por diversos ativos fitoquímicos dentre eles se destaca as antocianinas e as flavanonas, ativos esses presentes no extrato da espécie em no mínimo 90%. Estudos indicam que esses ativos são responsáveis por limitar o ganho de peso corporal, melhorar a sensibilidade à insulina e, diminuir os níveis séricos de triglicérides e de colesterol total. 10. Citrus sinensis is an extract obtained from Moro Vermelha Vermelha, also known as false blood. Moro red orange (Citrus sinensis L.) contains a variety of phytochemical components that contribute to the flavor and properties of the fruit. These substances include sugars like sucrose, fructose and glucose; organic acids (mainly citric, malic and isocitric acid); carotenoids, such as xanthophylls and carotenes; vitamins such as vitamin C, A, B1, B6 and B3; aromatic compounds, including various esters, alcohols, ketones, lactones and volatile hydrocarbons, in addition to polyphenols such as 8-hydroxycinnamic acid and bioflavonoids. Bioflavonoids are composed of several phytochemicals, among which anthocyanins and flavanones stand out, which are present in the species extract in at least 90%. Studies indicate that these assets are responsible for limiting body weight gain, improving insulin sensitivity and decreasing serum triglyceride and total cholesterol levels.
11. O Citrus sinensis apresenta também atividades anti-inflamatórias, antioxidante e cardioprotetora. 11. Citrus sinensis also has anti-inflammatory, antioxidant and cardioprotective activities.
12. Um estudo recente, publicado na conceituada revista International12. A recent study, published in the prestigious International magazine
Journal of Obesity, mostrou que os componentes presentes no extrato da laranja vermelha Moro agem sinergicamente, e reduzem o ganho de peso e o acúmulo de gordura induzida em animais alimentados com dieta hiperlipídica, com redução da gordura abdominal de 25 a 50%. O exame histológico do tecido adiposo também demostrou uma redução acentuada no tamanho dos adipócitos, devido à diminuição da capacidade de acumular gordura. Journal of Obesity, showed that the components present in the extract of Moro red orange act synergistically, and reduce the weight gain and the accumulation of fat induced in animals fed a high-fat diet, with a reduction in abdominal fat by 25 to 50%. Histological examination of adipose tissue also showed a marked reduction in the size of adipocytes, due to the decreased ability to accumulate fat.
13. Os componentes da fruta ajudavam a regular a produção de insulina, hormônio que regula a síntese de gordura. Associações sugeridas DM-II™ também atua no aumento da sensibilidade a insulina, redução do colesterol, manutenção da saúde cardiovascular e coadjuvante na redução de peso, desta forma sua associação com a13. The components of the fruit helped to regulate the production of insulin, a hormone that regulates the synthesis of fat. Suggested associations DM-II ™ also acts in increasing insulin sensitivity, lowering cholesterol, maintaining cardiovascular health and supporting weight reduction, thus its association with
Citrus Sinensis podem ser benéfico para controle de colesterol bem como redução de peso. Citrus Sinensis can be beneficial for cholesterol control as well as weight reduction.
14. Curcuma longa é utilizada tradicionalmente para múltiplas 5 14. Curcuma longa is traditionally used for multiple 5
enfermidades, sendo os rizomas a principal parte da planta empregada nas preparações. diseases, the rhizomes being the main part of the plant used in the preparations.
15. Os rizomas são principalmente empregados para tratamento de: feridas cutâneas (327-332), flatulências (330, 333, 334), dispepsia (330, 335, 336), artrite (327, 337), gastrite (334, 335), desordens hepáticas (332, 338), icterícia (330, 332), tosse (327, 339) e doenças de pele (337), como dermatite (334, 340), dermatomicoses (341 ), sarna (330, 342), infecções de pele (343) e parasitas de pele (344). Além disso, popularmente também é reportado o uso dos rizomas em casos de: diabetes (327), hanseníase (344), hirsutismo (344), úlceras causadas por HPV (344), coceira em erupções cutâneas (345), varíola (328), varicela (328), malária (346), sangramento pós-parto (347), injúria muscular (348), asma (330), vermes (342), tônico, revitalizador, estimulante (332, 336), febre, diarréia, expectorante e anti-inflamatório (334). 15. Rhizomes are mainly used to treat: skin wounds (327-332), flatulence (330, 333, 334), dyspepsia (330, 335, 336), arthritis (327, 337), gastritis (334, 335) , liver disorders (332, 338), jaundice (330, 332), cough (327, 339) and skin diseases (337), such as dermatitis (334, 340), dermatomycosis (341), scabies (330, 342), skin infections (343) and skin parasites (344). In addition, rhizomes are also popularly reported in cases of: diabetes (327), leprosy (344), hirsutism (344), ulcers caused by HPV (344), itchy skin rashes (345), smallpox (328) , chickenpox (328), malaria (346), postpartum bleeding (347), muscle injury (348), asthma (330), worms (342), tonic, revitalizer, stimulant (332, 336), fever, diarrhea, expectorant and anti-inflammatory (334).
16. A piperina (4) é composta por um grupo 1 ,3- benzodioxola (subunidade A), ao lado de uma cadeia de ácido pentadienoico (subunidade B) e o fragmento piperidina (subunidade C). O ácido pipérico, porção acil da molécula da piperina (subunidades A e B), tem como precursor o respectivo derivado cinamoil-SCoA (6), o qual é biossintetizado a partir do ácido chiquímico (5), podendo apresentar diferentes padrões de oxigenação no anel aromático (nos carbonos 3, 4 e 5), sendo que o anel 3,4-metilenodioxi é bastante comum na classe dos fenilpropanoides (C6- C3). 16. Piperine (4) is composed of a group 1, 3-benzodioxola (subunit A), next to a chain of pentadiene acid (subunit B) and the fragment piperidine (subunit C). Piperic acid, the acyl portion of the piperine molecule (subunits A and B), has as its precursor the respective cinnamoyl-SCoA derivative (6), which is biosynthesized from shikimic acid (5), and may present different oxygenation patterns in the aromatic ring (in carbons 3, 4 and 5), with the 3,4-methylenedioxy ring being quite common in the class of phenylpropanoids (C6-C3).
17. A luteína é um tipo de carotenoide e, como todos os outros, não é produzida pelo corpo humano. Possui funções importantes: é um filtro natural de luz azul, que protege os olhos e a pele de danos decorrentes no cotidiano devido à exposição à luz do dia e iluminação artificial dos ambientes. É também um relevante antioxidante que fornece proteção contra danos oxidativos de “radicais livres" produzidos por luz ultravioleta, fumaça de cigarro e poluição. As melhores fontes naturais de luteína são vegetais verdes e folhosos, como couve, espinafre, chicória, aipo e alface, legumes verdes, tubérculos vermelho-alaranjado, ervas frescas e gema de ovo. 17. Lutein is a type of carotenoid and, like all others, is not produced by the human body. It has important functions: it is a natural filter of blue light, which protects the eyes and skin from damage arising in daily life due to exposure to daylight and artificial lighting. environments. It is also a relevant antioxidant that provides protection against oxidative damage from “free radicals” produced by ultraviolet light, cigarette smoke and pollution. The best natural sources of lutein are green and leafy vegetables, such as kale, spinach, chicory, celery and lettuce, green vegetables, orange-red tubers, fresh herbs and egg yolk.
18. A astaxantina, carotenóide pertencente à classe das xantofilas, tem despertado grande interesse devido à sua capacidade antioxidante e possível papel na redução de risco de algumas doenças. A astaxantina pode ser encontrada naturalmente em microalgas como Haematococcus pluvialis e na levedura Phaffia rhodozyma como também tem sido considerada principal carotenóide em salmão e crustáceos. Os resíduos do processamento de camarão, geralmente descartados, são também importante fonte de astaxantina. A atividade antioxidante da astaxantina tem demonstrado importante função na modulação de funções biológicas relacionadas à peroxidação lipídica, desempenhando efeitos benéficos em doenças crónicas como doenças cardiovasculares, degeneração macular e câncer. Pesquisas têm demonstrado efeitos satisfatórios da astaxantina obtida de fontes naturais assim como da obtida sinteticamente, porém os estudos em humanos se limitam à utilização de fontes naturais. 18. Astaxanthin, a carotenoid belonging to the xanthophyll class, has aroused great interest due to its antioxidant capacity and possible role in reducing the risk of some diseases. Astaxanthin can be found naturally in microalgae such as Haematococcus pluvialis and in the yeast Phaffia rhodozyma as it has also been considered the main carotenoid in salmon and crustaceans. Shrimp processing residues, usually discarded, are also an important source of astaxanthin. The antioxidant activity of astaxanthin has demonstrated an important function in the modulation of biological functions related to lipid peroxidation, having beneficial effects in chronic diseases such as cardiovascular diseases, macular degeneration and cancer. Research has shown satisfactory effects of astaxanthin obtained from natural sources as well as that obtained synthetically, however studies in humans are limited to the use of natural sources.
19. Também chamados de minerais orgânicos, minerais quelatados ou mineral aminoácido quelato. São minerais ligados a um aminoácido e que possuem maior capacidade de serem absorvidos pelo organismo. Podem ser de três tipos: 1. Mineral Aminoácido Quelato: quando uma molécula de mineral está ligada a um aminoácido específico. É de fácil assimilação pelo organismo. 2. Mineral Aminoácido Complexo: (específico e inespecífico) quando uma molécula de mineral está ligada a um aminoácido complexo. É menos absorvida que o anterior. 3. Mineral Proteinato: quando uma molécula mineral está ligada a um complexo polipeptídico. É a menos absorvida dos três tipos: A diferença entre os três tipos está no peso molecular, na constante de estabilidade das ligações e nos aminoácidos utilizados. Os minerais quelatados possuem a vantagem de serem melhor biodisponíveis (até 90% de absorção, contra 10 a 20% dos minerais inorgânicos), sem interferirem na absorção de outros nutrientes, sem possuírem efeitos colaterais, nem causarem doppig. Para o calculo de correção de minerais quelatos deve-se levar em consideração a prescrição médica. Se o solicitado for apenas o mineral puro, o que chamamos de teor elementar, deve-se aplicar o fator. Se o prescrito for quelato, não. Para se certificar no momento da prescrição, o ideal é avaliar pela dosagem prescrita, assim sabemos se é prescrito o elementar ou não. O selênio oferece proteção contra diversos cânceres e, na verdade, contra um amplo espectro de doenças como: doenças crónicas, como arterosclerose (doença das artérias coronarianas, doença cerebrovascular e doença vascular periférica), câncer, doença degenerativa das articulações (artrite), cirrose e doença pulmonar obstrutiva crónica (enfisema). 19. Also called organic minerals, chelated minerals or chelated amino acid mineral. They are minerals linked to an amino acid and have a greater capacity to be absorbed by the body. They can be of three types: 1. Mineral Amino Acid Chelate: when a mineral molecule is linked to a specific amino acid. It is easily assimilated by the body. 2. Mineral Complex Amino Acid: (specific and nonspecific) when a mineral molecule is linked to a complex amino acid. It is less absorbed than the previous one. 3. Mineral Proteinate: when a mineral molecule is linked to a polypeptide complex. It is the least absorbed of the three types: The difference between the three types is in the molecular weight, the constant stability of bonds and the amino acids used. Chelated minerals have the advantage of being better bioavailable (up to 90% absorption, against 10 to 20% of inorganic minerals), without interfering with the absorption of other nutrients, without having side effects, or causing doppig. For calculating the correction of chelated minerals, medical prescription must be taken into account. If the request is only the pure mineral, which we call elementary content, the factor must be applied. If the prescription is chelated, no. To be sure at the time of prescription, the ideal is to evaluate by the prescribed dosage, so we know if the elementary is prescribed or not. Selenium offers protection against several cancers and, in fact, against a wide spectrum of diseases such as: chronic diseases, such as arterosclerosis (coronary artery disease, cerebrovascular disease and peripheral vascular disease), cancer, degenerative joint disease (arthritis), cirrhosis and chronic obstructive pulmonary disease (emphysema).
20. A Quercetina é um flavonoide antioxidante, que está presente nos alimentos na forma de glicosídeos natural pode ser verificado nos vegetais, frutas e sucos. Várias propriedades terapêuticas dos flavonoides, principalmente da Quercetina, têm sido estudadas nas últimas décadas, destacando-se o potencial antioxidante, anticarcinogênico e seus efeitos protetores aos sistemas renal, cardiovascular e hepático. É também um poderoso antioxidante e antirradicais livres, reduzindo o risco de morte por doenças das coronárias e diminuindo a incidência de enfarte do miocárdio. Apresenta- se sob a forma de um pó de coloração amarelo-ouro. 20. Quercetin is an antioxidant flavonoid, which is present in food in the form of natural glycosides and can be found in vegetables, fruits and juices. Various therapeutic properties of flavonoids, especially Quercetin, have been studied in recent decades, highlighting the antioxidant, anticarcinogenic potential and their protective effects on the renal, cardiovascular and hepatic systems. It is also a powerful antioxidant and free anti-radicals, reducing the risk of death from coronary heart disease and decreasing the incidence of myocardial infarction. Features- in the form of a yellow-gold powder.
21. A Bromelina é uma enzima digestiva de origem vegetal - Ananas comosus com ação antiinflamatória. Além de sua ação anti-inflamatória, tem sido estudada sua eficiência na inibição do desenvolvimento de células cancerígenas. Recomendação de uso Dosagens Baixas: 50 a 100 mg/dia, Dosagens Maiores: 500 mg/dia Empregada em processos inflamatórios de origem traumática, cirúrgico infeccioso, vascular e reumático. Propriedades Enzima digestiva, possui ação anti-inflamatória produzida pela ação fibrinolítica e antibradiquinínica das bromelinas. Indicações Empregada em processos inflamatórios de origem traumática, cirúrgico infeccioso, vascular e reumático. A Bromelina também pode ser usada como auxiliar na digestão e para o tratamento de queimaduras de grau elevado. 21. Bromelain is a digestive enzyme of plant origin - Ananas comosus with anti-inflammatory action. In addition to its anti-inflammatory action, its efficiency in inhibiting the development of cancer cells has been studied. Recommendation for use Low Dosages: 50 to 100 mg / day, Larger Dosages: 500 mg / day Used in inflammatory processes of traumatic origin, infectious, vascular and rheumatic surgery. Properties Digestive enzyme, it has an anti-inflammatory action produced by the fibrinolytic and anti-fibriniquinic action of bromelains. Indications Used in inflammatory processes of traumatic origin, infectious surgery, vascular and rheumatic. Bromelain can also be used as an aid in digestion and for the treatment of high-grade burns.
22. A vitamina C, ácido ascórbico, participa de diversas ações bioquímicas vitais para o organismo. Ela melhora o sistema imunológico, a pele, o humor e evita problemas oftalmológicos e derrames. O nutriente também conta com forte ação antioxidante, combatendo os radicais livres. 22. Vitamin C, ascorbic acid, participates in several biochemical actions vital to the body. It improves the immune system, the skin, the mood and prevents eye problems and strokes. The nutrient also has a strong antioxidant action, fighting free radicals.
23. Melhora a imunidade: A vitamina C aumenta a produção de glóbulos brancos, células que fazem parte do sistema imunológico e que tem a função de combater microorganismo e estruturas estranhas ao corpo. O nutriente também aumenta os níveis de anticorpos no organismo. Assim, o nutriente ajuda a fortalecer o sistema imunológico, deixando nosso corpo menos suscetível a doenças. 23. Improves immunity: Vitamin C increases the production of white blood cells, cells that are part of the immune system and that have the function of fighting microorganisms and foreign structures in the body. The nutrient also increases the levels of antibodies in the body. Thus, the nutrient helps to strengthen the immune system, making our body less susceptible to disease.
24. Evita o envelhecimento da pele: A vitamina C evita o envelhecimento da pele por ser essencial para a produção natural de colágeno pelo organismo. O colágeno é uma proteína que proporciona sustentação e firmeza para a pele. Além disso, a vitamina C tem ação antioxidante, ou seja, neutraliza os radicais livres, protegendo a pele contra a degradação de colágeno. 24 . Prevents skin aging: Vitamin C prevents skin aging as it is essential for the natural production of collagen by the body. Collagen is a protein that provides support and firmness to the skin. In addition, vitamin C has an antioxidant action, that is, it neutralizes free radicals, protecting the skin against collagen degradation.
25. Melhora a absorção de ferro: A vitamina C aumenta a biodisponibilidade de ferro não-heme, aquele de origem vegetal, no organismo. 25. Improves iron absorption: Vitamin C increases the bioavailability of non-heme iron, that of plant origin, in the body.
26. Proporciona resistência aos ossos: Isto ocorre porque a vitamina C é necessária para a produção de colágeno. Esta proteína além de ser benéfica para a pele, também proporciona resistência aos ossos, dentes, tendões e paredes dos vasos sanguíneos. 26. Provides resistance to bones: This is because vitamin C is necessary for the production of collagen. This protein is not only beneficial for the skin, but also provides resistance to bones, teeth, tendons and blood vessel walls.
27. Evita problemas de visão: A vitamina C contribui para prevenir problemas de visão em decorrência do envelhecimento. Isto porque o nutriente é um dos fatores para a prevenção da degeneração da mácula, parte da retina responsável pela percepção de detalhes. Outros nutrientes que evitam o problema são betacarotenos, vitamina E, zinco e cobre. 27. Prevents vision problems: Vitamin C contributes to prevent vision problems due to aging. This is because the nutrient is one of the factors for the prevention of macula degeneration, part of the retina responsible for the perception of details. Other nutrients that prevent the problem are beta-carotene, vitamin E, zinc and copper.
28. O lipedema é uma disfunção da distribuição de gordura, afetando quase exclusivamente as mulheres, cujos tecidos estão estruturados de forma diferente dos tecidos dos homens. É provável que a predisposição para o lipedema seja genética. A causa desta doença crónica são normalmente transformações hormonais no corpo, que acontecem durante a puberdade, uma gravidez ou a menopausa. Se a condição já existir, é provável que os sintomas se agravem nestes momentos da vida. 29. O lipedema caracteriza-se por um aumento do tecido adiposo subcutâneo (lipo-hipertrofia), inchaços na segunda metade do dia e dores nas pernas. As células adiposas do lipedema têm uma constituição diferente, p. ex., da reserva de gordura na barriga. 28. Lipedema is a dysfunction of fat distribution, affecting almost exclusively women, whose tissues are structured differently from men. The predisposition for lipedema is likely to be genetic. The cause of this chronic disease is usually hormonal changes in the body, which happen during puberty, pregnancy or menopause. If the condition already exists, the symptoms are likely to worsen at these times in life. 29. Lipedema is characterized by an increase in subcutaneous adipose tissue (lipohypertrophy), swelling in the second half of the day and pain in the legs. The fat cells of the lipedema have a different constitution, e.g. the fat reserve in the belly.
30. Praticamente só as mulheres são afetadas por lipedema. Assim sendo, os especialistas partem do princípio que as causas principais são hormonais. A doença manifesta-se, regra geral, no final da puberdade ou durante uma gravidez. Nos poucos homens em que se diagnosticam lipedema, frequentemente a sua origem é devido a alterações hormonais. 30. Virtually only women are affected by lipedema. Therefore, experts assume that the main causes are hormonal. The disease usually manifests itself at the end of puberty or during pregnancy. In the few men diagnosed with lipedema, its origin is often due to hormonal changes.
31. O lipedema não é uma reserva de gordura em consequência de peso excessivo, mas sim uma alteração patológica no tecido adiposo. Contudo, o peso excessivo e as oscilações de peso têm um efeito negativo sobre o lipedema. 31. Lipedema is not a fat reserve due to excessive weight, but rather a pathological change in adipose tissue. However, excessive weight and weight fluctuations have a negative effect on lipedema.
32. Ao contrário do linfedema, o lipedema é simétrico: causa alterações do tipo "coluna" e deformações das pernas. Quadril, coxas e pernas apresentam-se tipicamente volumosos. 32. Unlike lymphedema, lipedema is symmetrical: it causes changes in the "spine" type and deformations of the legs. Hips, thighs and legs are typically bulky.
33. Se a doença se estende mais para baixo, fala-se em Suaven trousers, visto que as deformações terminam, regra geral, nos tornozelos, sobrepostos pela gordura. A gordura do lipedema é sensível à dor por pressão e toque. Em estágios avançados, mesmo uma roupa mais justa já causa dor. Ao contrário do linfedema, no lipedema o sinal de Stemmer é sempre negativo. 33. If the disease extends further down, Suaven trousers are spoken of, as the deformations usually end in the ankles, overlapped by fat. Lipedema fat is sensitive to pressure and touch pain. In advanced stages, even tighter clothing already causes pain. Unlike lymphedema, in lipedema Stemmer's sign is always negative.
Inconvenientes observados atualmente: Currently observed drawbacks:
34. Nos casos possíveis, as operações de lipoaspiração são recomendadas, desde que, em seguida, não haja oscilações de peso nem um aumento súbito do peso. 35. Caso contrário, corre-se o perigo de se voltarem a formar pregas de gordura, ao fim de algum tempo. 34. In possible cases, liposuction operations are recommended, provided that there is then no fluctuation in weight or a sudden increase in weight. 35. Otherwise, there is a danger that fat folds will re-form after some time.
36. Por princípio, depois da lipoaspiração podem formar-se covas na pele, o que consegue ser amplamente evitado com a utilização de meias de compressão especiais. Antes da lipoaspiração, é impreterível esclarecer se o sistema linfático já está afetado pela doença, pois, nesse caso, tem de prescindir-se da lipoaspiração. 36. In principle, after liposuction pits can form in the skin, which can be largely avoided with the use of special compression stockings. Before liposuction, it is imperative to clarify whether the lymphatic system is already affected by the disease, as, in this case, it has to do without liposuction.
Solução: Solution:
37. Portanto, pensando em solucionar tais inconvenientes e em oferecer uma solução prática, segura e eficiente, foi desenvolvido o medicamento em questão. Apresentando ainda diversos benefícios, que podem ser destacados em: 37. Therefore, thinking about solving these inconveniences and offering a practical, safe and efficient solution, the drug in question was developed. Also presenting several benefits, which can be highlighted in:
• Tratamento medicamentoso; • Drug treatment;
• Evita transtornos gerais; • Avoids general disorders;
• Reduz custos, pois evita afastamento dos profissionais; • Reduces costs, as it avoids removal of professionals;
• Oferece mais praticidade no tratamento; • Offers more practical treatment;
• Exequibilidade industrial; • Industrial feasibility;
• Inovações merecedoras deste privilégio de patente. • Innovations worthy of this patent privilege.
Estado da técnica: State of the art:
38. Atualmente não são conhecidos nenhum tratamento medicamentoso e rémedio para o“Lipedema”. 38. Currently, no drug and remedy treatment for “Lipedema” is known.
39. Para uma perfeita visualização e compreensão da “MEDICAMENTO ORAL PARA TRATAR LIPEDEMA ", em questão, seguem os desenhos ilustrativos, onde: 39. For a perfect visualization and understanding of the “ORAL MEDICATION TO TREAT LIPEDEMA”, in question, follow the illustrative drawings, where:
40. A fig. 1— Apresenta uma vista ilustrativa de pernas com inchaços do lipedema em estágios iniciais aos mais avançados; 41. A fig. 2 - Apresenta uma vista ilustrativa do braço com inchaço do lipedema; 40. Fig. 1— It shows an illustrative view of legs with lipedema swelling in early to more advanced stages; 41. Fig. 2 - It shows an illustrative view of the arm with swelling of the lipedema;
42. A fig. 3 - Apresenta uma vista ilustrativa de coxas com inchaço do lipedema; 42. Fig. 3 - Shows an illustrative view of the thighs with swelling of the lipedema;
43. A fig. 4 - Apresenta uma vista do esquema de proposta biossintética para a formação da piperina; 43. Fig. 4 - It presents a view of the biosynthetic proposal scheme for the formation of piperine;
44. A fig. 5 - Apresenta uma vista do esquema de componentes químicos curcumina. 44. Fig. 5 - Displays a view of the chemical component curcumin scheme.
45. De acordo com a ilustração e em seus pormenores, o “ MEDICAMENTO ORAL PARA TRATAR LIPEDEMA é caracterizado por ser constituída de uma formula medicamentosa de uso oral para o tratamento do lipedema (1) em humanos (H) contendo: extrato seco de melão cataloupe equivalente a 480UI super óxido dismutase (2), pirroloquinolina quinona 5 mg (3), citrus sinensis 400 mg (4), curcumina 100 mg (5), piperina 2 mg (6), luteína 5 mg (7), astaxantina 1 mg (8), selênio quelato 100 mcg (9), vitamina C 100 mg (10), quercetina 300mg (11 ) e bromelina 180mg (12). 45. According to the illustration and in its details, the “ORAL MEDICATION TO TREAT LIPEDEMA is characterized by being a drug formulation for oral use for the treatment of lipedema (1) in humans (H) containing: dry melon extract cataloupe equivalent to 480UI super oxide dismutase (2), pyrroloquinoline quinone 5 mg (3), citrus sinensis 400 mg (4), curcumin 100 mg (5), piperine 2 mg (6), lutein 5 mg (7), astaxanthin 1 mg (8), selenium chelate 100 mcg (9), vitamin C 100 mg (10), quercetin 300mg (11) and bromelain 180mg (12).
46. Pelas vantagens que oferece e por revestir-se de características verdadeiramente inovadoras, o“MEDICAMENTO ORAL PARA TRATAR LIPEDEMA”, reúne as condições necessárias para merecer a Patente de Invenção. 46. Due to the advantages it offers and because it has truly innovative characteristics, the “ORAL MEDICATION TO TREAT LIPEDEMA”, brings together the necessary conditions to merit the Invention Patent.

Claims

REIVINDICAÇÕES
1a) “MEDICAMENTO ORAL PARA TRATAR UPEDEMA” é caracterízado por ser constituída de uma formula medicamentosa de uso oral para o tratamento do lipedema (1) em humanos (H) contendo; extrato seco de melão cataloupe equivalente 480UI super óxido dismutase (2), pirroloquinolina quinona 5 mg (3), cítrus sinensis 400 mg (4), curcumina 100 mg (5), piperina 2 mg (6), luteína 5 mg (7), astaxantina 1 mg (8), selênio quelato 100 mcg (9), vitamina C 100 mg (10), quercetina 300mg (11) e bromelina 180mg (12). 1 a ) “ORAL MEDICATION TO TREAT UPEDEMA” is characterized by being constituted of an oral medication formula for the treatment of lipedema (1) in humans (H) containing; dry extract of melon cataloupe equivalent 480UI super oxide dismutase (2), pyrroloquinoline quinone 5 mg (3), citrus sinensis 400 mg (4), curcumin 100 mg (5), piperine 2 mg (6), lutein 5 mg (7) , astaxanthin 1 mg (8), selenium chelate 100 mcg (9), vitamin C 100 mg (10), quercetin 300 mg (11) and bromelain 180 mg (12).
PCT/BR2019/000026 2019-07-12 2019-08-06 Oral medication for treating lipoedema WO2021007626A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRBR102019014449-1 2019-07-12
BR102019014449-1A BR102019014449A2 (en) 2019-07-12 2019-07-12 oral medicine to treat lipedema

Publications (1)

Publication Number Publication Date
WO2021007626A1 true WO2021007626A1 (en) 2021-01-21

Family

ID=74209630

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2019/000026 WO2021007626A1 (en) 2019-07-12 2019-08-06 Oral medication for treating lipoedema

Country Status (2)

Country Link
BR (1) BR102019014449A2 (en)
WO (1) WO2021007626A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160081974A1 (en) * 2014-09-18 2016-03-24 Research & Business Foundation Sungkyunkwan University Composition for preventing or treating edema containing flavonoid compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160081974A1 (en) * 2014-09-18 2016-03-24 Research & Business Foundation Sungkyunkwan University Composition for preventing or treating edema containing flavonoid compound

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOMBARDELLI, E.: "Phytosome: new cosmetic delivery system", BOLLETTINO CHIMICO FARMACEUTICO ( ITALY, vol. 130, 1991, pages 431 - 438, XP009032219 *
LEMAIRE B.; LE QUÉRÉ S.; SIMONEAU G.; LACAN D.: "Clinical trial of a natural and bioactive melon SuperOxide Dismutase (SOD B Dimpless®) on cellulite", PHYTOTHÉRAPIE, SPRINGER-VERLAG, PARIS, FR, vol. 14, no. 1, 29 September 2015 (2015-09-29), FR, pages 23 - 28, XP035895696, ISSN: 1624-8597, DOI: 10.1007/s10298-015-0977-4 *
NOUROLLAHI, S. ET AL.: "Bucher's broom and selenium improve lipedema: a retrospective case study", ALTERNATIVE AND INTEGRATIVE MEDICINE, vol. 2, no. 4, 2013, pages 1 - 7, XP055784233 *
RUSSE LL, Y.: "Curcumin for lipedema", SMORE NEWSLETTERS, 2015, pages 1 - 3, XP055784237, Retrieved from the Internet <URL:https://www.smore.com/5sg6c-curcumin-for-lipedema> [retrieved on 20190919] *

Also Published As

Publication number Publication date
BR102019014449A2 (en) 2021-01-19

Similar Documents

Publication Publication Date Title
Berger Can oxidative damage be treated nutritionally?
US20020146463A1 (en) Health promoting compositions
EP2032122B1 (en) Extracts of aphanizomenon flos aquae (afa klamath), active compounds, and their uses
US20080254135A1 (en) Resveratrol-containing compositions for general health and vitality
US20180042862A1 (en) Antioxidant dietary supplement compositions and methods for maintaining healthy skin
CA2627314C (en) Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves
US20050112210A1 (en) Eye nutritional supplement
Almodaifer et al. Role of phytochemicals in health and nutrition
Chandra et al. Pharmacological and nutritional importance of sea buckthorn (Hippophae)
Bhuvaneswari Antioxidants in oral healthcare
Yamagata Carotenoids regulate endothelial functions and reduce the risk of cardiovascular disease
US8067045B2 (en) Nutritional formulations and associated methods
Sarialtin et al. An overview on the role of macular xanthophylls in ocular diseases
US20200113982A1 (en) Composition and Uses Thereof
Gaikwad et al. Nutraceuticals Potential of Fat‐Soluble Vitamins
Stephen et al. Immune boosting functional components of natural foods and its health benefits
Hirdyani et al. Lutein—The less explored carotenoid
US20080075797A1 (en) Nutraceutical with Tart Cherries and Method of Treatment Therewith
US20050287131A1 (en) Health supplement
WO2021007626A1 (en) Oral medication for treating lipoedema
Khanum et al. Health food for soldiers
Brewer The Essential Guide to Vitamins, Minerals and Herbal Supplements
Poobalan et al. Medicinal properties of vegetable crops
Jadhav et al. Vitamins as a Nutraceutical for Blindness
Meletis et al. Natural remedies for promoting skin health

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19937801

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19937801

Country of ref document: EP

Kind code of ref document: A1